ELIZABETH SHPALL to Blood Component Removal
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Blood Component Removal.
Connection Strength
0.320
-
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System. J Vis Exp. 2015 Oct 05; (104).
Score: 0.125
-
Microbial contamination of hematopoietic progenitor cell products: clinical outcome. Bone Marrow Transplant. 2007 Aug; 40(4):365-8.
Score: 0.070
-
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support. Biol Blood Marrow Transplant. 2004 Jun; 10(6):415-25.
Score: 0.057
-
Mobilization and selection of CD34-positive hematopoietic progenitors. Blood Rev. 1996 Mar; 10(1):1-7.
Score: 0.032
-
Release of tumor cells from bone marrow. Blood. 1994 Feb 01; 83(3):623-5.
Score: 0.028
-
High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results. Bone Marrow Transplant. 1996 Sep; 18 Suppl 1:S26-9.
Score: 0.008